our Founder
Mark Siracusa, PhD
Mark is Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School where his research focuses on Mechanisms that promote immunity to helminth parasites and the development of allergic inflammation.
He received his PhD from Johns Hopkins in Molecular, Microbiology and Immunology and did his Post doc at the University of Pennsylvania under David Artis.
Mark has published in multiple prestigious journals including The Journal of Experimental Medicine, Nature Immunology, PLOS Pathogens, and Cell Reports and has received multiple grants, including 3 current R01 grants from the NIH
Leadership
Nicholas Shubin, PhD
Nicholas Shubin, PhD
Nicholas Shubin, PhD
Chief Executive Officer
Nick received his PhD from Brown University in Pathobiology and did his postdoc at Seattle Children’s Research Institute under Adrian Piliponsky, where he focused on understanding the roles of mast cells and basophils in acute inflammatory diseases. Nick has published research in journals such as Nature Immunology and Journal of Allergy and Clinical Immunology. Since completing his postdoc, Nick worked in Business Development for an immunoassay biotechnology company.
Nicholas Shubin, PhD
Nicholas Shubin, PhD
Research Team
Jianya Peng, PhD
Research Scientist
10+ years of experience in studying host immune response
Scientific advisory board/consultants
David Artis, PhD
Martin Devenport, PhD, MBA
Martin Devenport, PhD, MBA
Director, Jill Roberts Institute for Research in Inflammatory Bowel Disease and the Michael Kors Professor of Immunology, Department of Medicine at Weill Cornell
Martin Devenport, PhD, MBA
Martin Devenport, PhD, MBA
Martin Devenport, PhD, MBA
10 years of corporate experience in the biotech industry, with experience in all aspects of drug development, including R&D, GMP manufacturing, regulatory and clinical trials
John Piwinski, PhD
Martin Devenport, PhD, MBA
John Piwinski, PhD
Expertise in small molecule drug discovery with over 30 years of experience in medicinal chemistry
Board of Directors
Mark Siracusa, PhD
Mark Siracusa, PhD
Mark Siracusa, PhD
President of NemaGen Discoveries
James Golubieski
Mark Siracusa, PhD
Mark Siracusa, PhD
President of Foundation Venture Capital Group